Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C28H30O4 |
| Molecular Weight | 430.5354 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)C1=CC(=C(C)C=C1O)C2(OC(=O)C3=CC=CC=C23)C4=C(C)C=C(O)C(=C4)C(C)C
InChI
InChIKey=LDKDGDIWEUUXSH-UHFFFAOYSA-N
InChI=1S/C28H30O4/c1-15(2)20-13-23(17(5)11-25(20)29)28(22-10-8-7-9-19(22)27(31)32-28)24-14-21(16(3)4)26(30)12-18(24)6/h7-16,29-30H,1-6H3
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/13034620Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/29267665 | https://www.ncbi.nlm.nih.gov/pubmed/22788417
Sources: https://www.ncbi.nlm.nih.gov/pubmed/13034620
Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/29267665 | https://www.ncbi.nlm.nih.gov/pubmed/22788417
Thymolphthalein is a weak organic acid that behaves as an acid-base indicator in the pH range 9.3 (colorless) to 10.5 (blue). Thymolphthalein is also known to have been used as a laxative and for disappearing ink.
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Rational quantitative structure-activity relationship (RQSAR) screen for PXR and CAR isoform-specific nuclear receptor ligands. | 2010-12-05 |
|
| Ionic liquid "buffers"-pH control in ionic liquid systems. | 2010-11-07 |
|
| In vitro proliferation and osteoblastic phenotype expression of cells derived from human vertebral lamina and iliac crest. | 2009-07-01 |
|
| A colorimetric assay for steady-state analyses of iodo- and bromoperoxidase activities. | 2008-08-01 |
|
| Sensitive and rapid titrimetric and spectrophotometric methods for the determination of stavudine in pharmaceuticals using bromate-bromide and three dyes. | 2008-06 |
|
| Experimental correlation between the pKa value of sulfonphthaleins with the nature of the substituents groups. | 2008-04 |
|
| Genome-wide association with select biomarker traits in the Framingham Heart Study. | 2007-09-19 |
|
| On-line solid phase selective separation and preconcentration of Cd(II) by solid-phase extraction using carbon active modified with methyl thymol blue. | 2007-09-05 |
|
| Water-soluble pH-responsive dendritic core-shell nanocarriers for polar dyes based on poly(ethylene imine). | 2007-08-07 |
|
| Determination of the complexation constants of Pb(II) and Cd(II) with thymol blue using spectrophotometry, SQUAD and the HSAB principle. | 2007-01 |
|
| Simultaneous determination of copper, bismuth and lead by adsorptive stripping voltammetry in the presence of thymolphthalexone. | 2006-07 |
|
| Determination of transverse dispersion coefficients from reactive plume lengths. | 2006-03-25 |
|
| Surface consolidation of Pentelic marble: criteria for the selection of methods and materials. The Acropolis case. | 2005 |
|
| Spectrophotometric study of the system Hg(II)-thymol blue-H2O and its evidence through electrochemical means. | 2004-02 |
|
| A new continuous spectrophotometric assay method for DOPA oxidase activity of tyrosinase. | 2003-07 |
|
| A direct continuous pH-spectrophotometric assay for arginine kinase activity. | 2002-12 |
|
| Properties of small molecules affecting insulin receptor function. | 2001-11-13 |
|
| Spectrophotometric determination of sulfur dioxide in air, using thymol blue. | 2001-08-15 |
|
| Expression and kinetic properties of a recombinant 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase isoenzyme of human liver. | 1995-08 |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
THYMOLPHTHALEIN
Created by
admin on Mon Mar 31 21:15:08 GMT 2025 , Edited by admin on Mon Mar 31 21:15:08 GMT 2025
|
PRIMARY | |||
|
2186
Created by
admin on Mon Mar 31 21:15:08 GMT 2025 , Edited by admin on Mon Mar 31 21:15:08 GMT 2025
|
PRIMARY | |||
|
300000053620
Created by
admin on Mon Mar 31 21:15:08 GMT 2025 , Edited by admin on Mon Mar 31 21:15:08 GMT 2025
|
PRIMARY | |||
|
YG5I28WSQP
Created by
admin on Mon Mar 31 21:15:08 GMT 2025 , Edited by admin on Mon Mar 31 21:15:08 GMT 2025
|
PRIMARY | |||
|
m10826
Created by
admin on Mon Mar 31 21:15:08 GMT 2025 , Edited by admin on Mon Mar 31 21:15:08 GMT 2025
|
PRIMARY | Merck Index | ||
|
DTXSID2051633
Created by
admin on Mon Mar 31 21:15:08 GMT 2025 , Edited by admin on Mon Mar 31 21:15:08 GMT 2025
|
PRIMARY | |||
|
204-729-7
Created by
admin on Mon Mar 31 21:15:08 GMT 2025 , Edited by admin on Mon Mar 31 21:15:08 GMT 2025
|
PRIMARY | |||
|
125-20-2
Created by
admin on Mon Mar 31 21:15:08 GMT 2025 , Edited by admin on Mon Mar 31 21:15:08 GMT 2025
|
PRIMARY | |||
|
31316
Created by
admin on Mon Mar 31 21:15:08 GMT 2025 , Edited by admin on Mon Mar 31 21:15:08 GMT 2025
|
PRIMARY |
SUBSTANCE RECORD